Enteropathy-associated T-cell lymphoma: Difference between revisions
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}} | ||
{{SK}} | {{SK}} Enteropathy-type T-cell lymphoma; Intestinal T-cell lymphoma | ||
==[[Enteropathy-associated T-cell lymphoma overview|Overview]]== | ==[[Enteropathy-associated T-cell lymphoma overview|Overview]]== | ||
Revision as of 21:44, 26 January 2016
For patient information, click here
Enteropathy-associated T-cell lymphoma Microchapters |
Differentiating Enteropathy-associated T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Enteropathy-associated T-cell lymphoma On the Web |
American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma |
Risk calculators and risk factors for Enteropathy-associated T-cell lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Synonyms and keywords: Enteropathy-type T-cell lymphoma; Intestinal T-cell lymphoma
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Enteropathy-associated T-cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies